Skip to main content
HR 4640 116th Congress House

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

Official title: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Introduced: October 28, 2019 See on congress.gov
Health Drug safety, medical device, and laboratory regulationHealth programs administration and fundingHealth technology, devices, suppliesInflation and prices
More subjectsShow fewer subjects
Intellectual propertyMedical researchResearch and development
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 14, 2019
Referred to the Subcommittee on Health.
Oct 11, 2019
Referred to the House Committee on Energy and Commerce.
Oct 11, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 14, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 10
All 10 Democratic 10
D
García, Jesús G. "Chuy"
Illinois · Dec 23, 2019
 D
Pingree, Chellie
Maine · Dec 18, 2019
 D
Kaptur, Marcy
Ohio · Dec 3, 2019
 D
Cohen, Steve
Tennessee · Nov 18, 2019
 D
DeLauro, Rosa L.
Connecticut · Oct 31, 2019
 D
Schakowsky, Janice D.
Illinois · Oct 30, 2019
 D
Pocan, Mark
Wisconsin · Oct 28, 2019
 D
Welch, Peter
Vermont · Oct 22, 2019
 D
Khanna, Ro
California · Oct 21, 2019
 D
Doggett, Lloyd
Texas · Oct 18, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4640: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4640/
MLA
"H.R. 4640: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4640/.
Bluebook (legal)
H.R. 4640, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4640/.
Markdown link
[H.R. 4640: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019](https://openamerica.io/bill/116-HR-4640/)
Report a problem